Jazz Pharmaceuticals Plc (JAZZ) Directors and Executive Officers - CSIMarket
CSIMarket
 
Jazz Pharmaceuticals Plc  (NASDAQ: JAZZ)

Jazz Pharmaceuticals Plc

Officers & Directors


Executives:

1. Bruce C. Cozadd - Chairman, Chief Executive Officer, and Director (Principal Executive Officer)
2. Patricia Carr - Senior Vice President, Chief Accounting Officer (Principal Accounting Officer and Interim Principal Financial Officer)

Directors:

1. Kenneth W. O Keefe - Director
2. Anne O Riordan - Director
3. Norbert G. Riedel, Ph.D. - Director
4. Jennifer E. Cook - Director
5. Catherine A. Sohn, Pharm.D. - Director
6. Rick E. Winningham - Director
7. Patrick G. Enright - Director
8. Mark D. Smith, M.D. - Director
9. Seamus C. Mulligan - Director
10. Peter Gray - Director
11. Heather Ann McSharry - Director

Audit Firm:

- KPMG - Auditor since [year not specified].,

Jazz Pharmaceuticals Plc currently has 2890 employees.






JAZZ Management Effectiveness JAZZ Revenue per Employee JAZZ Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.